What’s New in CLL?
- Help us teach you best about MRD and Limited Duration Therapies by completing our Survey here
- Help move CLL patients to the front of the COVID-19 vaccine line by using our letter asking your state’s health department to move cancer patients to the front of the vaccine line. “Click, fill, send!“
- Dr. John Pagel: Why data from the ASH Annual Meetings should be on every CLL patient and caregiver’s radar
- EHA 2020: Dr. Matthew Davids on how COVID-19 is affecting clinical care for patients with CLL
- ASH 2020: Dr. Mato Discusses a Once Daily, Oral Triple Therapy Clinical Trial for Richter’s Transformation and De Novo Large B-Cell Lymphoma
- ASH 2020: Dr. Bill Wierda on CAR-T liso-cel combined with ibrutinib for CLL
Get The Best Care for Your Chronic Lymphocytic Leukemia (CLL)
The CLL Society Inc. is a patient–centric, physician–curated nonprofit organization focused on
patient education, support and research. Dedicated to addressing the unmet needs of the (CLL) chronic lymphocytic leukemia and
related blood cancer communities, we explain the rapidly changing therapeutic landscape and the importance of clinical trials,
support and build patient networks, engage in research and educate providers and patients.
CLL Society Expert Access™
Access to a CLL expert is critical to ensure receiving the best possible care and has proven to improve survival. In partnership with Verastem Oncology (Expert Access Founding Supporter), Genentech, and InfiniteMD, the CLL Society is proud to offer this free second opinion program for CLL patients.
We Are in this Together
-
Pingback: ABT-199 (venetoclax) in Combination Treatment for CLL